Discover 859 paid clinical trials in Tuscaloosa, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 859
Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
for
Cardiovascular, Comorbidity, Diabetes,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 50 - 70+
Code: NCT07748858
Recruiting
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
for
Uncontrolled Gout
Location: Birmingham AL, Newnan GA, Jackson TN, Marietta GA,
Sponsor: Amgen
Sex: All
Age: 18+
Code: NCT07388498
Phase3, Recruiting
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
for
Indolent Systemic Mastocytosis,
Location: Birmingham AL, Atlanta GA, Cincinnati OH, Houston TX,
Sponsor: Blueprint Medicines Corporation
Sex: All
Age: 18+
Code: NCT04910685
Phase2, Phase3, Recruiting
State of Hormones Impact Nociceptive Expression
for
Pain, Gender Identity
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 65
Code: NCT05787470
Recruiting
Remote Ischemic Conditioning Using the autoRIC
for
Ischemia-Reperfusion Injury
Location: Birmingham AL, Jacksonville FL, Charlotte NC,
Sponsor: CellAegis US, Inc.
Sex: All
Age: 18+
Code: NCT03318575
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Cardiometabolic Health Intervention Using Movement-to-Music Exercise
for
Cardiometabolic Risk Factors in Adult Wheelchair Users
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 70+
Code: NCT05606432
Recruiting
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
Location: Birmingham AL, Atlanta GA, Saint Louis MO, Houston TX,
Sponsor: TopAlliance Biosciences
Sex: All
Age: 18+
Code: NCT04137900
Phase1, Recruiting
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors